AKT1 and endometrial carcinoma: Although CD47 has been involved in cancer progression, at the cell level in vitro CD47 was discovered to be a critical part in enhancing cell migration ability, viability, and inhibiting apoptosis in endometrial carcinoma cells via the PI3K_Akt_mTOR Signaling Pathway [14].